A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks

Not Applicable

Completed

• Conditions: Sleep Disorder
• Interventions: Combination Product: Drinks with active ingredients such as poria and GABA

• Registration Number: NCT05908903
• Lead Sponsor: Botanee Group Co., Ltd.

Brief Summary

The main objective of the study is to observe changes in the subjects' sleep quality, skin condition and life status after 4 weeks of using a sleep aid drink (AOXMED Poria γ-aminobutyric acid drink).

This is a single-center, randomized, double-blind, controlled, 4-week (28-day) clinical study conducted in Chinese healthy women aged 25-55 years old who were offered a sleep aid drink.

Detailed Description

The study population is 70 healthy Chinese women aged 25-55 years with a PSQI ≥ 7 (presence of sleep disorder) who report current problems with dryness, roughness, dullness and lack of elasticity on their face. The subjects will be randomly divided into an experimental group and a control product group of 35 subjects each, and the distribution of age and total hours of sleep will be more or less equal in both groups.

Subjects will be formally enrolled after on-site assessment and will undergo follow-up site visits and test product administration. During the test cycle, subjects in the experimental group will take a drink with the active ingredients of Poria, Poria and GABA, and subjects in the control product group will take a control drink without Poria, Date Palm and GABA ingredients for 4 weeks. To avoid the influence of different skincare products on the results, all subjects will be asked to use the basic skincare products with only moisturizing ingredients provided by the sponsor during the test period. The efficacy of the test products will be verified by comparing the changes in sleep quality, skin condition and life status of the subjects before and after taking the test products for 2 and 4 weeks, and by comparing the differences in sleep quality, skin condition and life status between the test and control groups.

Study Timeline

• Study Start: 2022-07-09
• Primary Completion: 2022-08-07
• Study Completion: 2022-08-07
• Study First Submitted: 2023-05-29
• Status Verified: 2023-06
• Study First Submitted QC: 2023-06-08
• Last Update Submitted: 2023-06-08
• Study First Posted: 2023-06-18
• Last Update Posted: 2023-06-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

1. 25-55 years old, Chinese female;
2. PSQI index ≥ 7 (presence of sleep disorders);
3. The subject's self-reported facial problems such as dryness, roughness, dullness, and lack of elasticity;
4. The BMI of the subjects was between 18~24kg/m2;
5. After the doctor's clinical evaluation, there are mild facial skin roughness (1 point and above) and mild to moderate overall facial wrinkles (3~6 points);
6. Corneometer base measurement of facial skin moisture in 15~45 (Corneometer Unit, C.U.) Between;
7. Have basic Chinese reading ability;
8. can use smartphones;
9. Be in good health and free of any other chronic diseases other than skin problems and sleep disorders or diseases being treated;
10. Voluntarily participate in the test and sign the informed consent form; 11） Willingness to comply with all evaluation requirements;

Exclusion Criteria

1. Products with anti-wrinkle, firming, repairing and nourishing effects are not included in the skin care products used;
2. Intend to become pregnant, or are pregnant or breastfeeding;
3. Have a history of alcoholism;
4. Have a history of allergies;
5. Participated in any clinical trial evaluation within 1 month;
6. Those who have applied any anti-inflammatory drugs to the test site within the past two months;
7. Those who have suffered from skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.);
8. patients with insulin-dependent diabetes;
9. Patients with asthma or other chronic respiratory diseases who are being treated;
10. Have taken/injected anti-allergic drugs in the past 1 month;
11. Patients who have received anti-cancer chemotherapy or immunotherapy patients within the past 6 months;
12. Have any other health problems or chronic diseases;
13. Applying retinoids, A hydroxy acids, salicylic acids, hydroquinone within the past 3 months, or prescription drugs (antibiotics, retinoids, A hydroxy acids and steroids) in use within the past 6 months, oral contraceptives (if you have been taking the same contraceptive pills for the past 6 months, you can continue to take them);
14. Experts or professionals believe that there are other iatrogenic reasons that will affect the evaluation results; 15) Those who have undergone surgery, plastic surgery or organ transplantation in the past year.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental Group	Drinks with active ingredients such as poria and GABA	Take drinks with active ingredients such as poria and GABA. Drink half an hour before bedtime, 10ml/bag/day, daily.
Control product group	Drinks with active ingredients such as poria and GABA	Take a control drink that does not contain GABA and poria. Drink half an hour before bedtime, 10ml/bag/day, daily.

Primary Outcome Measures

Name	Time	Method
Changes in the Pittsburgh Sleep Quality Index	Week0（Baseline）、Week2、Week4	Obtain change from Baseline PSQI index at 2 weeks by questionnaire. Obtain change from Baseline PSQI index at 4 weeks by questionnaire.
Changes in the sleep duration	Week0（Baseline）、Week2、Week4	Obtain change from Baseline sleep duration at 2 weeks by sleep quality monitoring bracelet.; Obtain change from Baseline sleep duration at 4 weeks by sleep quality monitoring bracelet.
Sleep Quality Assessment after 4-week application	Week4	Obtain data on agreement with sleep improvement by sleep quality self-assessment questionnaire
Sleep Quality Assessment after 2-week application	Week2	Obtain data on agreement with sleep improvement by sleep quality self-assessment questionnaire

Secondary Outcome Measures

Name	Time	Method
Changes in the skin elasticity	Week0（Baseline）、Week2、Week4	Obtain change from Baseline skin elasticity at 2 weeks by cutometer. Obtain change from Baseline skin elasticity at 4 weeks by cutometer.
Changes in the grade of skin dryness	Week0（Baseline）、Week2、Week4	Obtain change from Baseline grade of skin dryness at 2 weeks by Dermatologist evaluation according to 5-point dryness scale.; Obtain change from Baseline grade of skin dryness at 4 weeks by Dermatologist evaluation according to 5-point dryness scale.
Skin condition Assessment after 2-week application	Week2	Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire
Changes in the satisfaction with the quality of life	Week0（Baseline）、Week2、Week4	Obtain change from Baseline satisfaction with the quality of life at 2 weeks accessed by WHOQOL-100 questionnaire.; Obtain change from Baseline satisfaction with the quality of life at 4 weeks accessed by WHOQOL-100 questionnaire.
Changes in the skin hydration	Week0（Baseline）、Week2、Week4	Obtain change from Baseline skin hydration at 2 weeks by Corneometer. Obtain change from Baseline skin hydration at 4 weeks by Corneometer.
Changes in the individual type angle	Week0（Baseline）、Week2、Week4	Obtain change from Baseline Individual type angle at 2 weeks by Colorimeter. Obtain change from Baseline Individual type angle at 4 weeks by Colorimeter.
Changes in the proportion of crow's feet area	Week0（Baseline）、Week2、Week4	Calculate the proportion of crow's feet area by Visia CR images. Obtain change from Baseline proportion of crow's feet area at 2 weeks. Obtain change from Baseline proportion of crow's feet area at 4 weeks.
Changes in the proportion of fine lines under the eye	Week0（Baseline）、Week2、Week4	Calculate the proportion of fine lines under the eye by Visia CR images. Obtain change from Baseline proportion of fine lines under the eye at 2 weeks. Obtain change from Baseline proportion of fine lines under the eye at 4 weeks.
Changes in the skin glossiness	Week0（Baseline）、Week2、Week4	Obtain change from Baseline skin glossiness at 2 weeks by Glossymeter. Obtain change from Baseline skin glossiness at 4 weeks by Glossymeter.
Changes in the skin firmness	Week0（Baseline）、Week2、Week4	Obtain change from Baseline skin firmness at 2 weeks by cutometer. Obtain change from Baseline skin firmness at 4 weeks by cutometer.
Changes in the degree of wrinkle severity	Week0（Baseline）、Week2、Week4	Obtain change from Baseline degree of wrinkle severity at 2 weeks by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type.; Obtain change from Baseline degree of wrinkle severity at 4 weeks by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type.
Skin condition Assessment after 4-week application	Week4	Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire
Changes in the CIE RGB of skin tone	Week0（Baseline）、Week2、Week4	Dermatologist use PANTONE SkinTone (Pantone color card) skin color guide to evaluate skin tone grade of subjects. Find the CIE RGB corresponding to the skin tone grade in Pantone ColorManager software and convert it into a color value using the formula for data analysis: CIE RGB = R+G\*256+B\*256\*256.; Calculate the change from Baseline CIE RGB of skin tone at 2 weeks. Calculate the change from Baseline CIE RGB of skin tone at 4 weeks.

Trial Locations

Locations (1)

Shanghai China-norm Quality Technical Service Co ，Ltd; 🇨🇳 Shanghai, Shanghai, China